Published in Brain Res Bull on September 01, 1981
Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. Proc Natl Acad Sci U S A (1983) 1.95
Ascorbic acid stimulates gonadotropin release by autocrine action by means of NO. Proc Natl Acad Sci U S A (2001) 0.80
Monitoring in vivo of transmitter metabolism by electrochemical methods. Biochem J (1983) 0.75
Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med (1978) 2.15
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Botulinum toxin injection after biliary sphincterotomy. Endoscopy (2004) 1.76
Monitoring of transmitter metabolites by voltammetry in cerebrospinal fluid following neural pathway stimulation. Nature (1976) 1.52
Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med (1982) 1.45
Probing brain chemistry with electroanalytical techniques. Anal Chem (1976) 1.44
Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res (1984) 1.34
Voltammetry in brain tissue--a new neurophysiological measurement. Brain Res (1973) 1.28
New high performance liquid chromatographic analysis of brain catecholamines. Life Sci (1974) 1.19
Potential oxidative pathways of brain catecholamines. J Med Chem (1976) 1.16
Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology (1988) 1.16
Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release. Life Sci (1978) 1.15
Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sci (1976) 1.15
Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain. J Neurochem (1991) 1.12
Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proc Natl Acad Sci U S A (1978) 1.10
Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods (1981) 1.09
Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am J Psychiatry (1983) 1.03
Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res (1994) 1.01
Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem (1992) 1.00
Determination of catecholamines in tissue and body fluids using microbore HPLC with amperometric detection. Life Sci (1985) 0.99
The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry. Brain Res (1991) 0.99
Voltammetry in brain tissue: quantitative studies of drug interactions. Brain Res (1974) 0.98
Catecholamines, dopamine, and endorphin levels during extreme exercise. N Engl J Med (1981) 0.98
Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 0.97
In vivo voltammetry: monitoring of dopamine metabolites in CSF following release by electrical stimulation. Brain Res (1978) 0.97
Electrocoating carbon fiber microelectrodes with Nafion improves selectivity for electroactive neurotransmitters. J Neurosci Methods (1987) 0.96
Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom Med (1983) 0.96
Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience (1985) 0.94
Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol (1985) 0.94
Lateralization of norepinephrine in human thalamus. Science (1978) 0.94
Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes. J Neurochem (1990) 0.93
Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Aliment Pharmacol Ther (2006) 0.93
Catecholamine secretion as a function of perceived coping self-efficacy. J Consult Clin Psychol (1985) 0.92
In vivo dynamics of norepinephrine release-reuptake in multiple terminal field regions of rat brain. J Neurochem (1994) 0.92
Oral tolerance in myasthenia gravis. Ann N Y Acad Sci (1996) 0.92
Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res (1982) 0.91
Electrochemical studies of the oxidation pathways of catecholamines. J Am Chem Soc (1967) 0.91
Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Ann Neurol (1983) 0.90
Serum melatonin and pineal indoleamine metabolism in a species with a small day/night N-acetyltransferase rhythm. Comp Biochem Physiol B (1985) 0.89
Liquid chromatographic monitoring of CSF metabolites. Brain Res (1977) 0.89
Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res (1979) 0.89
Effect of single and repeated electroconvulsive shock on the hypothalamic-pituitary-adrenal axis and plasma catecholamines in rats. Psychopharmacology (Berl) (1989) 0.88
[In vivo continuous electrochemical determination of dopamine release in rat neostriatum]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.88
Detailed mapping of ascorbate distribution in rat brain. Neurosci Lett (1982) 0.87
Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res (1986) 0.87
Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide. Muscle Nerve (1982) 0.87
Electrochemical assay for brain ascorbate with ascorbate oxidase. Anal Chem (1982) 0.86
Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. Ann Neurol (1990) 0.86
Voltammetry in brain tissue: the fate of injected 6-hydroxydopamine. Brain Res (1974) 0.85
Single-dose ethanol administration activates the hypothalamic-pituitary-adrenal axis: exploration of the mechanism of action. Neuroendocrinology (1989) 0.85
Repeated coronary artery spasm in a young woman with the eosinophilia-myalgia syndrome. JAMA (1992) 0.85
Hippocampal 5-HT1A receptor binding site densities, 5-HT1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats. Behav Brain Res (1996) 0.85
Chronoamperometry in brain slices: quantitative evaluations of in vivo electrochemistry. Brain Res (1983) 0.85
Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol (1989) 0.85
Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: clinical relevance. Ann N Y Acad Sci (1981) 0.84
Stimulant drug treatment of hyperactivity: biochemical correlates. Clin Pharmacol Ther (1990) 0.84
Experiences with the treatment of alkaline reflux gastritis. Surgery (1980) 0.84
Regional distribution of ascorbate in human brain. Brain Res (1981) 0.83
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy. Ann Oncol (2007) 0.83
Electrochemical pretreatment of carbon fibers for in vivo electrochemistry: effects on sensitivity and response time. Anal Chem (1987) 0.83
Both the sigma receptor-specific ligand (+)3-PPP and the PCP receptor-specific ligand TCP act in the mouse vas deferens via augmentation of electrically evoked norepinephrine release. Eur J Pharmacol (1987) 0.83
Rapid nocturnal increase in ovine pineal N-acetyltransferase activity and melatonin synthesis: effects of cycloheximide. J Neurochem (1985) 0.83
Detailed mapping of ascorbate distribution in rat brain. Neurosci Lett (1982) 0.83
Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res (1990) 0.83
Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res (1991) 0.83
Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophr Bull (1987) 0.82
Ascorbic acid distribution patterns in human brain. A comparison with nonhuman mammalian species. Ann N Y Acad Sci (1987) 0.82
Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis. Ann Neurol (1980) 0.82
Real-time monitoring of electrically stimulated norepinephrine release in rat thalamus: II. Modeling of release and reuptake characteristics of stimulated norepinephrine overflow. J Neurochem (1993) 0.81
Catecholamine distribution patterns in rat thalamus. Brain Res (1983) 0.81
Amphetamine dose-dependent changes of in vivo electrochemical signals in rat caudate. Brain Res (1979) 0.81
Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res (1990) 0.81
Elevated dopamine/norepinephrine ratios in thalami of schizophrenic brains. Biol Psychiatry (1988) 0.81
Biomedical uses of high-performance liquid chromatography with electrochemical detection. Methods Biochem Anal (1985) 0.81
Regional differences in resting extracellular potassium levels of rat brain. Brain Res (1987) 0.81
Determination of tryptophan and metabolites in rat brain and pineal tissue by reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr (1980) 0.81
Determination of reduced glutathione in guinea pig and rat tissue by HPLC with electrochemical detection. Life Sci (1978) 0.81
Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Psychiatry Res (1991) 0.81
Reciprocal day/night relationship between serotonin oxidation and N-acetylation products in the rat pineal gland. Endocrinology (1983) 0.81
Hemispheric asymmetry of norepinephrine distribution in rat thalamus. Brain Res (1980) 0.81
Isolation and identificaton of an in vivo reaction product of 6-hydroxydopamine. J Med Chem (1977) 0.80
Narcolepsy: biogenic amine deficits in an animal model. Science (1983) 0.80
Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy. J Clin Endocrinol Metab (2000) 0.80
First cut, then blend: an electrocautery technique affecting bleeding at sphincterotomy. Endoscopy (2001) 0.80
Three-dimensional mapping of norepinephrine and serotonin in human thalamus. Brain Res (1997) 0.80
Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy. Ann N Y Acad Sci (2003) 0.80
Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study. Brain Res (1991) 0.80
Applications of modern electroanalytical techniques to pharmaceutical chemistry. J Pharm Sci (1969) 0.80
CSF dopamine levels correlate with extraversion in depressed patients. Psychiatry Res (1986) 0.80
Simultaneous voltammetric and chemical monitoring of dopamine release in situ. Brain Res (1985) 0.80
Simultaneous determination of catecholamines and unconjugated 3,4-dihydroxyphenylacetic acid in brain tissue by ion-pairing reverse-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem (1980) 0.79
Comparison of the effects of voltage-sensitive calcium channel antagonism on the electrically stimulated release of dopamine and norepinephrine in vivo. Brain Res (1993) 0.79
Femtogram detection limits for biogenic amines using microbore HPLC with electrochemical detection. Brain Res (1984) 0.79
Simultaneous monitoring of voltammetric and ion-selective electrodes in mammalian brain. Neurosci Lett (1985) 0.79
Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment. Brain Res (1978) 0.79
Electrochemical oxidation pathways of benzo [a] pyrene. J Am Chem Soc (1970) 0.79
6-Hydroxydopamine, a new oxidation mechanism. Eur J Pharmacol (1972) 0.79